If you can become pregnant and take isotretinoin for severe adult acne, planned home pregnancy tests do not count yet. Until November 15, 2026, you must follow the prior iPLEDGE rules for clinic-based testing. iPLEDGE is the shared safety program that controls isotretinoin prescriptions to prevent harm to an unborn baby.
The National Community Pharmacists Association summarizes that the Food and Drug Administration approved changes on Feb. 9, 2026 to reduce patient, prescriber and pharmacy burden while keeping protection against embryo-fetal toxicity National Community Pharmacists Association summary. The start was first set for August 2026, then moved later for system work.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Official resources:
- Explore the official data from FDA — Use this primary source to review the underlying data.
- Read the official guidance from Ncpa — Use this primary source to verify the official guidance.
Table of Contents
- Can you use a home test now?
- What home testing is planned after Nov. 15?
- Why does the first test stay in the clinic?
- What must happen before each monthly refill?
- What pregnancy prevention still applies?
Can you use a home test now?
No. Prior testing rules apply until the cutover. Lachman Consultants reports that FDA delayed implementation to Nov.
15, 2026 to allow more testing of iPLEDGE updates and avoid treatment interruptions Lachman Consultants report. Keep scheduling pregnancy tests in a medical setting. Ask your clinic which tests it accepts and when results must arrive before your prescription date.
What home testing is planned after Nov. 15?
After cutover, prescribers may allow pregnancy testing outside a medical setting, such as home tests, during and after treatment. The FDA medical organizations letter states this option, while keeping stricter rules for the first dose FDA medical organizations letter.
The change removes the requirement for a CLIA-certified laboratory, according to Dermatology Times reporting. A home test is not automatic. Your prescriber must approve it for you.
Why does the first test stay in the clinic?
All testing before the first dose of a treatment course must still occur in a medical setting. That rule stays even when later home tests are allowed.
The same clinic rule applies to a repeat test if you missed the pickup window and have not taken the first dose. FDA also eliminated the 19-day lockout after a missed 7-day pickup window, so a repeat test can occur immediately without added waiting.
What must happen before each monthly refill?
Patients who can become pregnant and take isotretinoin for severe nodular or refractory acne, including adult acne patients, must enroll in iPLEDGE. They need a verified negative pregnancy test before each monthly prescription, according to Medaptly reporting on the FDA safety program.
When outside-setting tests are allowed, the prescriber must set up steps to receive results and reduce misreading or false results. The prescriber or designee must verify and document the negative result before writing each prescription.
What pregnancy prevention still applies?
FDA isotretinoin labeling states that patients who can become pregnant must use two forms of birth control at once or abstain from sex for one month before, during, and one month after treatment FDA isotretinoin labeling. Even brief exposure can cause severe birth defects. Useful planning steps include:.
- Start the required birth control or abstinence a full month before isotretinoin.
- Keep both methods in place through treatment and for one month after the last dose.
- Tell your prescriber right away about missed doses, unprotected sex, or a late period.
You Might Also Like
- Planned Home Pregnancy Testing Under the 2026 iPLEDGE Changes: Timeline and Transition Questions for Adult Acne Patients
- Pretreatment Pregnancy Testing Under iPLEDGE in 2026: Timeline and Transition Questions for Adult Acne Patients
- Fish Oil With Low-Dose Isotretinoin in a 2026 Randomized Trial: Study Design and Evidence Limits for Adults With Persistent Acne